For a deeper look at appetite changes and how these medications work, see our GLP-1 support overview
23 April 2025 A Correction to this paper has been published: Abbreviations BBB: Bloodbrain barrier CNS: Central Nervous System GFAP: Glial fibrillary acidic protein GLP-1R: Glucagon-like peptide-1 receptor HFD: Highfat diet IB4: Biotinylated isolectin B4 Iba-1: Ionized calciumbinding adaptor molecule-1 ND: Normolipid diet NVU: Neurovascular unit SAL: Saline solution SEMA: Semaglutide References Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C
In particular, dysregulation of the gut-liver-muscle-brain axis, driven by hyperammonemia, systemic inflammation, sarcopenia, altered bile acid signaling, and gut dysbiosis, plays an important role in the pathogenesis and progression of CHE [9, 10]
Cycle Length: 4 weeks of daily dosing, followed by 24 weeks off to evaluate progress and allow receptor resetting